BRKR Bruker Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: BRKR

Price (delayed)

$59.04

Market cap

$9.04B

P/E Ratio

57.88

Dividend/share

$0.16

EPS

$1.02

Enterprise value

$9.34B

Sector: Healthcare
Industry: Medical Devices
Website: https://www.bruker.com/

Highlights

BRKR's equity is up by 13% YoY and by 6% QoQ
Bruker's debt has soared by 53% YoY but it has decreased by 18% from the previous quarter
The quick ratio has increased by 35% YoY but it has decreased by 7% from the previous quarter
BRKR's price to earnings (P/E) is 56% higher than its last 4 quarters average of 37.1 and 54% higher than its 5-year quarterly average of 37.7
The net income has declined by 24% year-on-year and by 4.3% since the previous quarter

Key stats

What are the main financial stats of BRKR
Market
Shares outstanding
153.11M
Market cap
$9.04B
Enterprise value
$9.34B
Valuations
Price to earnings (P/E)
57.88
Price to book (P/B)
9.49
Price to sales (P/S)
4.61
EV/EBIT
40.65
EV/EBITDA
30.45
EV/Sales
4.77
Earnings
Revenue
$1.96B
EBIT
$229.9M
EBITDA
$306.9M
Free cash flow
$168.9M
Per share
EPS
$1.02
Free cash flow per share
$1.1
Book value per share
$6.22
Revenue per share
$12.79
TBVPS
$14.63
Balance sheet
Total assets
$2.88B
Total liabilities
$1.92B
Debt
$872M
Equity
$952.1M
Working capital
$1.14B
Liquidity
Debt to equity
0.92
Current ratio
2.67
Quick ratio
1.39
Net debt/EBITDA
0.99
Margins
EBITDA margin
15.7%
Gross margin
47.1%
Net margin
8%
Operating margin
12.9%
Efficiency
Return on assets
5.5%
Return on equity
17.2%
Return on invested capital
12.5%
Return on capital employed
10.5%
Return on sales
11.7%
Dividend
Dividend yield
0.27%
DPS
$0.16
Payout ratio
15.7%

BRKR stock price

How has the Bruker stock price performed over time
Intraday
0.51%
1 week
0.1%
1 month
8.21%
1 year
9.9%
YTD
9.07%
QTD
9.07%

Financial performance

How have Bruker's revenue and profit performed over time
Revenue
$1.96B
Gross profit
$923.1M
Operating income
$253.2M
Net income
$157.5M
Gross margin
47.1%
Net margin
8%
The net income has declined by 24% year-on-year and by 4.3% since the previous quarter
Bruker's net margin has decreased by 22% YoY and by 4.8% from the previous quarter
BRKR's operating income is down by 13% year-on-year and by 2.5% since the previous quarter
BRKR's operating margin is down by 10% YoY and by 2.3% QoQ

Growth

What is Bruker's growth rate over time

Valuation

What is Bruker stock price valuation
P/E
57.88
P/B
9.49
P/S
4.61
EV/EBIT
40.65
EV/EBITDA
30.45
EV/Sales
4.77
BRKR's price to earnings (P/E) is 56% higher than its last 4 quarters average of 37.1 and 54% higher than its 5-year quarterly average of 37.7
BRKR's EPS is down by 23% year-on-year and by 4.7% since the previous quarter
The stock's price to book (P/B) is 46% more than its 5-year quarterly average of 6.5 and 36% more than its last 4 quarters average of 7.0
BRKR's equity is up by 13% YoY and by 6% QoQ
The stock's price to sales (P/S) is 65% more than its 5-year quarterly average of 2.8 and 44% more than its last 4 quarters average of 3.2
Bruker's revenue has decreased by 3.3% YoY

Efficiency

How efficient is Bruker business performance
Bruker's return on invested capital has decreased by 42% YoY and by 9% QoQ
BRKR's return on assets is down by 40% year-on-year and by 8% since the previous quarter
Bruker's return on equity has decreased by 27% YoY and by 7% QoQ
BRKR's return on sales is down by 12% year-on-year and by 3.3% since the previous quarter

Dividends

What is BRKR's dividend history
DPS
$0.16
Dividend yield
0.27%
Payout ratio
15.7%
Recent dividends

Financial health

How did Bruker financials performed over time
BRKR's total assets is 50% greater than its total liabilities
The quick ratio has increased by 35% YoY but it has decreased by 7% from the previous quarter
BRKR's total liabilities is up by 28% YoY but it is down by 6% QoQ
Bruker's debt is 8% less than its equity
Bruker's debt has soared by 53% YoY but it has decreased by 18% from the previous quarter
BRKR's debt to equity is up by 37% year-on-year but it is down by 23% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.